** OncoGenex Pharmaceuticals of Bothell puts cancer drug placed on fast track
OncoGenex Pharmaceuticals in Bothell has received fast-track designation from the U.S. FDA for its cancer drug OGX-011, potentially speeding up its approval process for prostate cancer treatment. This news led to a 64 percent surge in the company's stock price.